Skip to main content
Clinical Trials/IRCT20200825048515N57
IRCT20200825048515N57
Recruiting
Phase 3

Investigating the preventive effect of dexmedetomidine infusion on recovery indicators after rhinoplasty surgery under general anesthesia

Esfahan University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Rhinoplasty.
Sponsor
Esfahan University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age range18 to 65 years
  • Rhinoplasty surgery candidate under general anesthesia
  • American Society of Anesthesiology (ASA) class one and two
  • Consent to participate in the study

Exclusion Criteria

  • The history of previous allergy to dexmedetomidine
  • body mass index (BMI) above 30 kg/m2
  • Taking painkillers or neuropsychiatric drugs before the intervention

Outcomes

Primary Outcomes

Not specified

Similar Trials